Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 DNA vaccines for immunodeficiency viruses.

× No keyword cloud information.

13 in total

1. Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins.

Authors: T M Ross; Y Xu; T D Green; D C Montefiori; H L Robinson
Journal: AIDS Res Hum Retroviruses Date: 2001-06-10 Impact factor: 2.205

2. Protection of Macaca nemestrina from disease following pathogenic simian immunodeficiency virus (SIV) challenge: utilization of SIV nucleocapsid mutant DNA vaccines with and without an SIV protein boost.

Authors: R J Gorelick; R E Benveniste; J D Lifson; J L Yovandich; W R Morton; L Kuller; B M Flynn; B A Fisher; J L Rossio; M Piatak; J W Bess; L E Henderson; L O Arthur
Journal: J Virol Date: 2000-12 Impact factor: 5.103

3. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.

Authors: J M Binley; R W Sanders; B Clas; N Schuelke; A Master; Y Guo; F Kajumo; D J Anselma; P J Maddon; W C Olson; J P Moore
Journal: J Virol Date: 2000-01 Impact factor: 5.103

4. HIV Vaccine Strategies - an Update.

Authors: A K Sahni; A Nagendra
Journal: Med J Armed Forces India Date: 2011-07-21

5. Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140.

Authors: P L Earl; W Sugiura; D C Montefiori; C C Broder; S A Lee; C Wild; J Lifson; B Moss
Journal: J Virol Date: 2001-01 Impact factor: 5.103

6. Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.

Authors: J P McGettigan; S Sarma; J M Orenstein; R J Pomerantz; M J Schnell
Journal: J Virol Date: 2001-09 Impact factor: 5.103

7. Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodies.

Authors: Kelly R Young; Benjamin E Teal; Yvonne Brooks; Thomas D Green; Joseph F Bower; Ted M Ross
Journal: AIDS Res Hum Retroviruses Date: 2004-11 Impact factor: 2.205

8. Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d.

Authors: Joseph F Bower; Xinzhen Yang; Joseph Sodroski; Ted M Ross
Journal: J Virol Date: 2004-05 Impact factor: 5.103

9. Mucosal adjuvanticity of a Shigella invasin complex with dna-based vaccines.

Authors: Robert W Kaminski; K Ross Turbyfill; C Chao; W M Ching; Edwin V Oaks
Journal: Clin Vaccine Immunol Date: 2009-02-18

10. Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting.

Authors: J F Richmond; S Lu; J C Santoro; J Weng; S L Hu; D C Montefiori; H L Robinson
Journal: J Virol Date: 1998-11 Impact factor: 5.103